These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7498868)

  • 1. [Treatment of depressive symptoms with a high concentration hypericum preparation. A multicenter placebo-controlled double-blind study].
    Witte B; Harrer G; Kaptan T; Podzuweit H; Schmidt U
    Fortschr Med; 1995 Oct; 113(28):404-8. PubMed ID: 7498868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R; Trautmann-Sponsel RD; Kieser M
    Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Tahmacebi-Pour N; Noorbala AA; Amini H; Fallah-Pour H; Jamshidi AH; Khani M
    Phytother Res; 2005 Feb; 19(2):148-51. PubMed ID: 15852492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
    Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
    Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
    Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
    Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
    Darbinyan V; Aslanyan G; Amroyan E; Gabrielyan E; Malmström C; Panossian A
    Nord J Psychiatry; 2007; 61(5):343-8. PubMed ID: 17990195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
    Kasper S; Dienel A
    Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.
    Kieser M; Szegedi A
    Pharmacopsychiatry; 2005 Sep; 38(5):194-200. PubMed ID: 16189745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
    Fabre LF; Abuzzahab FS; Amin M; Claghorn JL; Mendels J; Petrie WM; Dubé S; Small JG
    Biol Psychiatry; 1995 Nov; 38(9):592-602. PubMed ID: 8573661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
    Singer A; Schmidt M; Hauke W; Stade K
    Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.
    Zhang ZJ; Tan QR; Tong Y; Li Q; Kang WH; Zhen XC; Post RM
    J Affect Disord; 2008 Jul; 109(1-2):91-7. PubMed ID: 18093662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
    Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St John's wort or sertraline? Randomized controlled trial in primary care.
    van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
    Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.